| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.18B | +25.5% |
| R&D Expense | $6.0M | +39.5% |
| SG&A Expense | $682.0M | +48.4% |
| Operating Income | $351.0M | +42.1% |
| Interest Expense | $15.0M | +61.3% |
| Pre-tax Income | $195.0M | — |
| Income Tax | $48.0M | +116.2% |
| Net Income | $119.0M | -48.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $964.0M | -20.5% |
| Accounts Receivable | $742.0M | +112.8% |
| Current Assets | $2.18B | +14.2% |
| Total Assets | $8.71B | +72.8% |
| Current Liabilities | $1.31B | -4.8% |
| Long-term Debt | $4.55B | +60.0% |
| Total Liabilities | $6.76B | +67.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $634.0M | +26.7% |
| Capital Expenditures | $10.0M | +40.8% |
| Investing Cash Flow | -$3.00B | -333.8% |
| Financing Cash Flow | $2.06B | +121.2% |
| Free Cash Flow | $624.0M | +26.5% |
| Stockholders' Equity |
| $1.44B |
| +78.8% |